Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 6 of 6 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/22
End: 02/03/23
Due: 02/03/24
Phase: N/A
Priority: Normal
Start: 08/10/21
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 01/10/23
End: 07/31/32
Due: 07/31/33
Phase: N/A
Priority: Normal
Start: 04/03/21
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/11/20
End: 08/16/21
Due: 08/16/22
Phase: N/A
Priority: Normal
Start: 03/10/25
End: 12/31/28
Due: 12/31/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ALLEVIATE-HF-HD Study | NCT05501652 | Alleviant Medical, Inc. | user2@example.com | None | 2022-06-30 | 2023-02-03 | 2024-02-03 | - | - | 2025-07-14 |
| ALLEVIATE-HFrEF Study | NCT05133089 | Alleviant Medical, Inc. | user2@example.com | None | 2021-08-10 | 2022-06-01 | 2023-06-01 | - | - | 2025-07-14 |
| Alleviant ALLAY-HF Study | NCT05685303 | Alleviant Medical, Inc. | user2@example.com | None | 2023-01-10 | 2032-07-31 | 2033-07-31 | - | - | 2025-07-14 |
| Alleviate-HF-2 Study | NCT04838353 | Alleviant Medical, Inc. | user2@example.com | None | 2021-04-03 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| Alleviate-HF-1 Study | NCT04583527 | Alleviant Medical, Inc. | user2@example.com | None | 2020-08-11 | 2021-08-16 | 2022-08-16 | - | - | 2025-07-14 |
| Alleviant ALLAY-HFrEF Study | NCT06812533 | Alleviant Medical, Inc. | user2@example.com | None | 2025-03-10 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |